Abstract:Puerariae Flos, a representative homology plant of medicine and food for alcoholism, has a long history of clinical experience and remarkable curative effect in the treatment of alcoholic liver disease (ALD). However, its effective forms and hepatoprotective mechanisms remain unknown. In the present study, a strategy based on UPLC-QTOF MS combined with mass defect filtering technique was established for comprehensive mapping of the metabolic profile of PF in rat plasma, urine, bile, and feces after oral administration. Furthermore, the absorbed constituents into plasma and bile with a relatively high level were subjected to the network analysis, functional enrichment analysis, and molecular docking to clarify the potential mechanism. Finally, the therapeutic effect of PF on ALD and predicted mechanisms were further evaluated using a rat model of alcohol-induced liver injury and Western blot analysis. In total, 25 prototype components and 82 metabolites, including 93 flavonoids, 13 saponins, and one phenolic acid, were identified or tentatively characterized in vivo . In addition, glucuronidation, sulfation, methylation, hydroxylation, and reduction were observed as the major metabolic pathways of PF. The constructed compound–target–pathway network revealed that 11 absorbed constituents associated with the 16 relevant targets could be responsible for the protective activity of PF against ALD by regulating nine pathways attributable to glycolysis/gluconeogenesis, amino acid metabolism, and lipid regulation as well as inflammation and immune regulation. In addition, four active ingredients (6′′-O-xylosyltectoridin, genistein-7-glucuronide-4′-sulfate, tectoridin-4′-sulfate, and 6′′-O-xylosyltectoridin-4′-sulfate) as well as two target genes (MAO-A and PPAR-α) were screened and validated to play a crucial role with a good molecular docking score. The present results not only increase the understanding on the effective form and molecular mechanisms of PF-mediated protection against ALD but also promote better application of PF as a supplement food and herbal medicine for the treatment of ALD.

UHPLC-FT-ICR-MS Combined with Serum Pharmacochemistry for Bioactive Compounds Discovery of Zhi-Zi-Da-Huang-decoction Against Alcohol-Induced Hepatotoxicity in Rats

A plasma untargeted metabolomic study of Chinese medicine Zhi-Zi-Da-Huang decoction intervention to alcohol-induced hepatic steatosis

An untargeted metabolomics-driven approach based on LC–TOF/MS and LC–MS/MS for the screening of xenobiotics and metabolites of Zhi-Zi-Da-Huang decoction in rat plasma

Dynamic Metabolic Profile of Zhi-Zi-Da-Huang Decoction in Rat Urine Based on Hybrid Liquid Chromatography-Mass Spectrometry Coupled with Solid Phase Extraction

Dynamic Metabolic Profiling of Urine Biomarkers in Rats with Alcohol-Induced Liver Damage Following Treatment with Zhi-Zi-Da-Huang Decoction

Identification of Absorbed Components and Metabolites of Zhi-Zi-Hou-Po Decoction in Rat Plasma after Oral Administration by an Untargeted Metabolomics-Driven Strategy Based on LC-MS

Metabolic profile elucidation of Zhi–Zi–Da–Huang decoction in rat intestinal bacteria using high-resolution mass spectrometry combined with multiple analytical perspectives

Network Pharmacology-Based Antioxidant Effect Study of Zhi-Zi-Da-Huang Decoction for Alcoholic Liver Disease

Plasma metabolic profiling analysis of normal and ANIT-induced cholestasis rats after oral administration of Da-Huang-Xiao-Shi decoction using UHPLC-Q-Orbitrap MS coupled with pattern recognition

An effective integrated method for comprehensive identification of eighty-five compounds in Zhi-Zi-Da-Huang decoction by HPLC-DAD-ESI-MS (TOF) and HPLC-DAD-ESI-MS/MS (QqQ) without the help of reference standards

[Identification of the Lignans Components after Oral Administration of Fuzheng Huayu Decoction in Rat Serum by HPLC-MSn].

Mass spectrometry assessment of the protective effects of Zhizi Dahuang decoction on alcoholic liver injury

Characterization of Global Metabolic Profile of Zhi-Zi-Hou-Po Decoction in Rat Bile, Urine and Feces after Oral Administration Based on a Strategy Combining LC–MS and Chemometrics

UPLC-MS-based Metabonomic Analysis of Intervention Effects of Da-Huang-Xiao-Shi Decoction on ANIT-induced Cholestasis.

Study of Xuanhuang Pill in protecting against alcohol liver disease using ultra-performance liquid chromatography/time-of-flight mass spectrometry and network pharmacology

Metabolomics Approach to Identify Therapeutically Potential Biomarkers of the Zhi-Zi-Da-Huang Decoction Effect on the Hepatoprotective Mechanism

Identification of prototype compounds and their metabolites in rats' serum from Xuefu Zhuyu Decoction by UPLC-Q-TOF/MS

Pharmacokinetics-based comprehensive strategy to identify multiple effective components in Huangqi decoction against liver fibrosis

Studies on chemical constituents of Flos Puerariae‐Semen Hoveniae medicine pair by HPLC and Fourier transform ion cyclotron resonance mass spectrometry

Systematic characterization of Puerariae Flos metabolites in vivo and assessment of its protective mechanisms against alcoholic liver injury in a rat model

Evaluation of Zhenwu Decoction Effects on CYP450 Enzymes in Rats Using a Cocktail Method by UPLC-MS/MS